| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PD-1/PD-L1-IN-22
CAS:2159063-12-2
Package:1removed
|
Acetamide, N-[2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-methoxyphenyl]methyl]amino]ethyl]- manufacturers
- PD-1/PD-L1-IN-22
-
- $1520.00 / 25mg
-
2026-04-21
- CAS:2159063-12-2
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Acetamide, N-[2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-methoxyphenyl]methyl]amino]ethyl]- Basic information |
| | Acetamide, N-[2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-methoxyphenyl]methyl]amino]ethyl]- Chemical Properties |
| Boiling point | 665.3±55.0 °C(Predicted) | | density | 1.332±0.06 g/cm3(Predicted) | | pka | 16.11±0.46(Predicted) |
| | Acetamide, N-[2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-methoxyphenyl]methyl]amino]ethyl]- Usage And Synthesis |
| Uses | PD-1/PD-L1-IN-22 (Example 2) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-22 blocks PD-1/PD-L1 with the IC50 of 0.732 μM. PD-1/PD-L1-IN-22 can be used for the research of cancers, infectious diseases and autoimmune diseases[1]. | | References | [1] Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof. WO2017202276A1. |
| | Acetamide, N-[2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-methoxyphenyl]methyl]amino]ethyl]- Preparation Products And Raw materials |
|